Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Schizophrenia | 55 | 2022 | 464 | 5.670 |
Why?
|
Genome-Wide Association Study | 46 | 2023 | 1620 | 3.380 |
Why?
|
Homosexuality, Male | 7 | 2021 | 298 | 2.350 |
Why?
|
Polymorphism, Single Nucleotide | 41 | 2023 | 2356 | 1.700 |
Why?
|
Heterosexuality | 4 | 2021 | 17 | 1.700 |
Why?
|
Gender Identity | 2 | 2021 | 52 | 1.500 |
Why?
|
Genetic Linkage | 18 | 2021 | 623 | 1.370 |
Why?
|
Genetic Predisposition to Disease | 36 | 2023 | 2270 | 1.360 |
Why?
|
Mental Disorders | 9 | 2021 | 371 | 1.200 |
Why?
|
Depressive Disorder, Major | 8 | 2023 | 158 | 1.030 |
Why?
|
Genome, Human | 12 | 2021 | 756 | 0.900 |
Why?
|
Induced Pluripotent Stem Cells | 5 | 2022 | 104 | 0.850 |
Why?
|
Bipolar Disorder | 15 | 2021 | 377 | 0.810 |
Why?
|
Genetic Variation | 12 | 2018 | 1351 | 0.770 |
Why?
|
DNA Copy Number Variations | 10 | 2022 | 171 | 0.640 |
Why?
|
Chromosomes, Human, Pair 8 | 3 | 2014 | 85 | 0.630 |
Why?
|
Sequence Analysis, RNA | 3 | 2018 | 217 | 0.610 |
Why?
|
Humans | 99 | 2023 | 86601 | 0.590 |
Why?
|
General Practitioners | 1 | 2016 | 12 | 0.580 |
Why?
|
Transcriptome | 4 | 2018 | 580 | 0.580 |
Why?
|
Genotype | 22 | 2019 | 1850 | 0.580 |
Why?
|
Male | 51 | 2021 | 40956 | 0.570 |
Why?
|
Chromosome Mapping | 19 | 2015 | 1074 | 0.550 |
Why?
|
Gene Expression Regulation | 7 | 2018 | 1920 | 0.530 |
Why?
|
Family | 3 | 2009 | 311 | 0.500 |
Why?
|
Chromosomes, Human, X | 1 | 2014 | 55 | 0.500 |
Why?
|
Patient Participation | 1 | 2016 | 216 | 0.500 |
Why?
|
Sexual Behavior | 3 | 2021 | 302 | 0.490 |
Why?
|
Referral and Consultation | 1 | 2016 | 326 | 0.470 |
Why?
|
Communication | 1 | 2016 | 440 | 0.440 |
Why?
|
Genetic Loci | 5 | 2023 | 250 | 0.440 |
Why?
|
Gene Expression Profiling | 3 | 2017 | 1384 | 0.430 |
Why?
|
Female | 47 | 2021 | 44507 | 0.430 |
Why?
|
Chromosomes, Human, Pair 6 | 6 | 2009 | 125 | 0.420 |
Why?
|
Parity | 1 | 2012 | 93 | 0.420 |
Why?
|
Phenotype | 10 | 2021 | 2377 | 0.420 |
Why?
|
Alleles | 14 | 2022 | 1127 | 0.420 |
Why?
|
Receptors, Serotonin | 2 | 2002 | 34 | 0.420 |
Why?
|
Case-Control Studies | 13 | 2019 | 1804 | 0.420 |
Why?
|
Fertility | 1 | 2012 | 115 | 0.410 |
Why?
|
Chromatin | 3 | 2020 | 380 | 0.410 |
Why?
|
Multifactorial Inheritance | 4 | 2019 | 158 | 0.410 |
Why?
|
Siblings | 3 | 2021 | 111 | 0.400 |
Why?
|
Linkage Disequilibrium | 13 | 2016 | 473 | 0.400 |
Why?
|
Mothers | 1 | 2012 | 141 | 0.390 |
Why?
|
Quantitative Trait Loci | 6 | 2020 | 576 | 0.390 |
Why?
|
Decision Making | 1 | 2016 | 642 | 0.390 |
Why?
|
Haplotypes | 7 | 2008 | 642 | 0.390 |
Why?
|
Genetic Markers | 10 | 2016 | 476 | 0.360 |
Why?
|
Psychotic Disorders | 4 | 2021 | 184 | 0.350 |
Why?
|
Chromosomes, Human, Pair 22 | 2 | 2005 | 43 | 0.330 |
Why?
|
Catechol O-Methyltransferase | 2 | 2008 | 68 | 0.320 |
Why?
|
Adult | 23 | 2018 | 25640 | 0.320 |
Why?
|
Internet | 1 | 2010 | 312 | 0.310 |
Why?
|
Lod Score | 9 | 2021 | 152 | 0.300 |
Why?
|
Genetics, Behavioral | 2 | 2004 | 22 | 0.300 |
Why?
|
Body Height | 3 | 2013 | 99 | 0.300 |
Why?
|
Pedigree | 15 | 2012 | 966 | 0.290 |
Why?
|
Brain | 6 | 2020 | 2216 | 0.290 |
Why?
|
Body Mass Index | 4 | 2015 | 770 | 0.270 |
Why?
|
Sequence Deletion | 2 | 2019 | 205 | 0.270 |
Why?
|
Suicide, Attempted | 3 | 2023 | 128 | 0.260 |
Why?
|
Base Sequence | 9 | 2017 | 2330 | 0.250 |
Why?
|
Gene Frequency | 10 | 2014 | 677 | 0.250 |
Why?
|
Cell Adhesion Molecules | 1 | 2005 | 163 | 0.250 |
Why?
|
Phosphoproteins | 1 | 2005 | 254 | 0.240 |
Why?
|
Gene Regulatory Networks | 2 | 2018 | 296 | 0.240 |
Why?
|
Middle Aged | 15 | 2018 | 25017 | 0.230 |
Why?
|
Psychopharmacology | 1 | 2002 | 26 | 0.220 |
Why?
|
Population Health | 1 | 2022 | 33 | 0.210 |
Why?
|
Schizophrenic Psychology | 2 | 2012 | 129 | 0.210 |
Why?
|
Chromosomes, Human, Pair 13 | 3 | 2017 | 51 | 0.210 |
Why?
|
Chromosomes, Human, Pair 18 | 6 | 1999 | 42 | 0.210 |
Why?
|
Risk Factors | 9 | 2023 | 5416 | 0.210 |
Why?
|
Biological Evolution | 1 | 2009 | 918 | 0.200 |
Why?
|
Nicotine | 2 | 2021 | 194 | 0.200 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2022 | 96 | 0.200 |
Why?
|
Sex Characteristics | 2 | 2021 | 319 | 0.200 |
Why?
|
Chromosomes, Human, Pair 15 | 3 | 2016 | 63 | 0.190 |
Why?
|
Sexual Partners | 1 | 2021 | 93 | 0.190 |
Why?
|
Adolescent | 10 | 2018 | 8979 | 0.190 |
Why?
|
Choice Behavior | 1 | 2021 | 160 | 0.180 |
Why?
|
Proteome | 1 | 2001 | 124 | 0.180 |
Why?
|
Homosexuality, Female | 1 | 2019 | 15 | 0.180 |
Why?
|
Neurons | 4 | 2022 | 1546 | 0.170 |
Why?
|
Behavior, Addictive | 1 | 2021 | 130 | 0.170 |
Why?
|
Receptor, Serotonin, 5-HT1B | 3 | 2003 | 8 | 0.170 |
Why?
|
Dopamine Antagonists | 1 | 2018 | 35 | 0.160 |
Why?
|
Dopamine | 2 | 2018 | 275 | 0.160 |
Why?
|
Sexual and Gender Minorities | 1 | 2021 | 192 | 0.160 |
Why?
|
Smoking | 2 | 2012 | 609 | 0.160 |
Why?
|
X Chromosome Inactivation | 1 | 2017 | 28 | 0.160 |
Why?
|
Receptors, Thyrotropin | 1 | 2017 | 47 | 0.160 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2017 | 49 | 0.160 |
Why?
|
DNA | 2 | 2002 | 1294 | 0.150 |
Why?
|
Body Size | 2 | 2015 | 91 | 0.150 |
Why?
|
Chromosomes, Human | 3 | 2009 | 66 | 0.150 |
Why?
|
Neurogenesis | 1 | 2018 | 74 | 0.150 |
Why?
|
Hippocampus | 1 | 2001 | 442 | 0.150 |
Why?
|
Informed Consent | 1 | 2019 | 266 | 0.150 |
Why?
|
Genetic Diseases, Inborn | 1 | 1997 | 101 | 0.150 |
Why?
|
Molecular Sequence Annotation | 2 | 2016 | 67 | 0.150 |
Why?
|
Brain Diseases | 1 | 2018 | 180 | 0.150 |
Why?
|
Nervous System | 1 | 2017 | 86 | 0.150 |
Why?
|
Obesity | 3 | 2013 | 963 | 0.140 |
Why?
|
Genome | 1 | 2019 | 372 | 0.140 |
Why?
|
Paternal Inheritance | 1 | 2016 | 3 | 0.140 |
Why?
|
Prader-Willi Syndrome | 1 | 2016 | 8 | 0.140 |
Why?
|
Angelman Syndrome | 1 | 2016 | 7 | 0.140 |
Why?
|
Models, Genetic | 3 | 2016 | 926 | 0.140 |
Why?
|
Cell Line | 3 | 2018 | 2468 | 0.140 |
Why?
|
Statistics as Topic | 1 | 2017 | 238 | 0.140 |
Why?
|
Patient Outcome Assessment | 1 | 2016 | 84 | 0.140 |
Why?
|
Fetus | 2 | 2016 | 226 | 0.140 |
Why?
|
Educational Status | 1 | 2016 | 188 | 0.130 |
Why?
|
Autism Spectrum Disorder | 1 | 2016 | 76 | 0.130 |
Why?
|
Young Adult | 6 | 2018 | 5974 | 0.130 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2012 | 487 | 0.130 |
Why?
|
Molecular Sequence Data | 7 | 2014 | 3030 | 0.130 |
Why?
|
United Kingdom | 3 | 2021 | 164 | 0.130 |
Why?
|
Educational Measurement | 1 | 2016 | 225 | 0.130 |
Why?
|
Chromosomes, Human, Pair 7 | 2 | 2013 | 79 | 0.120 |
Why?
|
Membrane Proteins | 2 | 2017 | 1196 | 0.120 |
Why?
|
Chromosomes, Human, Pair 3 | 2 | 2011 | 54 | 0.120 |
Why?
|
Arthritis, Rheumatoid | 1 | 2015 | 166 | 0.120 |
Why?
|
Williams Syndrome | 1 | 2013 | 4 | 0.120 |
Why?
|
Autistic Disorder | 2 | 2012 | 147 | 0.120 |
Why?
|
MicroRNAs | 2 | 2017 | 534 | 0.120 |
Why?
|
Hydroxymethylbilane Synthase | 1 | 1993 | 1 | 0.110 |
Why?
|
United States | 6 | 2022 | 6665 | 0.110 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2013 | 79 | 0.110 |
Why?
|
Anthropometry | 1 | 2013 | 74 | 0.110 |
Why?
|
Sequence Analysis, DNA | 4 | 2019 | 853 | 0.110 |
Why?
|
Aged | 8 | 2018 | 18402 | 0.110 |
Why?
|
Amino Acid Substitution | 2 | 2005 | 339 | 0.100 |
Why?
|
Cohort Studies | 5 | 2022 | 2767 | 0.100 |
Why?
|
Gene Expression | 5 | 2010 | 1284 | 0.100 |
Why?
|
Apoptosis | 1 | 2018 | 1683 | 0.100 |
Why?
|
Europe | 5 | 2012 | 309 | 0.100 |
Why?
|
Receptors, Nicotinic | 1 | 2012 | 129 | 0.100 |
Why?
|
Nerve Tissue Proteins | 2 | 2012 | 503 | 0.100 |
Why?
|
Tobacco Use Disorder | 1 | 2012 | 108 | 0.100 |
Why?
|
Epigenesis, Genetic | 1 | 2015 | 479 | 0.100 |
Why?
|
Polymorphism, Genetic | 3 | 2004 | 819 | 0.100 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 2002 | 100 | 0.090 |
Why?
|
Amino Acid Sequence | 4 | 2002 | 2062 | 0.090 |
Why?
|
Risk | 3 | 2020 | 674 | 0.090 |
Why?
|
Self-Assessment | 1 | 2010 | 47 | 0.090 |
Why?
|
Personality Assessment | 1 | 2010 | 98 | 0.090 |
Why?
|
Metabolic Networks and Pathways | 1 | 2010 | 79 | 0.090 |
Why?
|
Chromosome Deletion | 1 | 2011 | 229 | 0.090 |
Why?
|
Gene-Environment Interaction | 3 | 2016 | 103 | 0.090 |
Why?
|
Population Surveillance | 1 | 2011 | 219 | 0.090 |
Why?
|
Birth Order | 1 | 2009 | 8 | 0.090 |
Why?
|
Alcoholism | 1 | 2011 | 172 | 0.090 |
Why?
|
Body Weight | 1 | 2010 | 459 | 0.090 |
Why?
|
Hair | 1 | 2009 | 56 | 0.090 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2008 | 12 | 0.080 |
Why?
|
RNA | 1 | 2013 | 560 | 0.080 |
Why?
|
RNA Stability | 2 | 2013 | 86 | 0.080 |
Why?
|
Functional Laterality | 1 | 2009 | 201 | 0.080 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2008 | 93 | 0.080 |
Why?
|
Synapses | 2 | 2022 | 265 | 0.080 |
Why?
|
Quality Control | 1 | 2008 | 117 | 0.080 |
Why?
|
Age of Onset | 4 | 2012 | 310 | 0.080 |
Why?
|
Polymorphism, Restriction Fragment Length | 2 | 2001 | 147 | 0.080 |
Why?
|
Neoplasms | 1 | 2022 | 2897 | 0.080 |
Why?
|
RNA, Messenger | 3 | 2003 | 1981 | 0.080 |
Why?
|
Meta-Analysis as Topic | 3 | 2013 | 87 | 0.070 |
Why?
|
Prevalence | 1 | 2010 | 1239 | 0.070 |
Why?
|
Genomics | 2 | 2022 | 720 | 0.070 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2006 | 106 | 0.070 |
Why?
|
Follow-Up Studies | 3 | 2008 | 3636 | 0.070 |
Why?
|
Thioredoxin Reductase 2 | 1 | 2005 | 2 | 0.070 |
Why?
|
Promoter Regions, Genetic | 3 | 2017 | 937 | 0.070 |
Why?
|
Thioredoxin-Disulfide Reductase | 1 | 2005 | 4 | 0.070 |
Why?
|
Armadillo Domain Proteins | 1 | 2005 | 3 | 0.070 |
Why?
|
Databases, Factual | 2 | 2001 | 812 | 0.070 |
Why?
|
Pregnancy | 1 | 2012 | 2893 | 0.060 |
Why?
|
Waist-Hip Ratio | 2 | 2015 | 18 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 1621 | 0.060 |
Why?
|
Carrier Proteins | 1 | 2007 | 673 | 0.060 |
Why?
|
Nucleic Acid Conformation | 2 | 2003 | 332 | 0.060 |
Why?
|
Receptors, Dopamine | 1 | 2003 | 38 | 0.060 |
Why?
|
Suicidal Ideation | 1 | 2023 | 67 | 0.060 |
Why?
|
Signal Transduction | 1 | 2013 | 3241 | 0.050 |
Why?
|
Disease Susceptibility | 3 | 1998 | 193 | 0.050 |
Why?
|
Cloning, Molecular | 3 | 1998 | 646 | 0.050 |
Why?
|
Communicable Disease Control | 1 | 2022 | 51 | 0.050 |
Why?
|
Cell Cycle Proteins | 1 | 2004 | 388 | 0.050 |
Why?
|
Sulfurtransferases | 1 | 2021 | 6 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2018 | 1458 | 0.050 |
Why?
|
Electrophoresis | 1 | 2001 | 55 | 0.050 |
Why?
|
Rats, Inbred F344 | 1 | 2021 | 156 | 0.050 |
Why?
|
Mental Health | 1 | 2022 | 162 | 0.050 |
Why?
|
Computational Biology | 2 | 2016 | 528 | 0.050 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2021 | 70 | 0.050 |
Why?
|
Adoption | 2 | 2011 | 9 | 0.050 |
Why?
|
Brain Chemistry | 1 | 2001 | 121 | 0.050 |
Why?
|
Microsatellite Repeats | 4 | 2002 | 144 | 0.050 |
Why?
|
Sp4 Transcription Factor | 2 | 2010 | 2 | 0.050 |
Why?
|
Chromosomes, Human, Pair 21 | 2 | 1997 | 54 | 0.050 |
Why?
|
Logistic Models | 3 | 2011 | 1185 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2004 | 696 | 0.040 |
Why?
|
DNA, Complementary | 2 | 1997 | 393 | 0.040 |
Why?
|
Datasets as Topic | 1 | 2019 | 71 | 0.040 |
Why?
|
Mutation | 2 | 2003 | 3967 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2022 | 319 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2018 | 6501 | 0.040 |
Why?
|
Enhancer Elements, Genetic | 1 | 2020 | 266 | 0.040 |
Why?
|
Endothelial Cells | 1 | 2021 | 428 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2011 | 689 | 0.040 |
Why?
|
Receptors, LDL | 1 | 1998 | 53 | 0.040 |
Why?
|
Calcium | 1 | 2022 | 1156 | 0.040 |
Why?
|
DNA Footprinting | 1 | 2017 | 18 | 0.040 |
Why?
|
RNA Editing | 1 | 1998 | 34 | 0.040 |
Why?
|
Quantitative Trait, Heritable | 1 | 2018 | 124 | 0.040 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 1997 | 51 | 0.040 |
Why?
|
Genes | 1 | 1998 | 305 | 0.040 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 2 | 1996 | 30 | 0.040 |
Why?
|
Multigene Family | 1 | 1997 | 202 | 0.040 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1997 | 126 | 0.040 |
Why?
|
Dendrites | 1 | 2017 | 99 | 0.040 |
Why?
|
Animals | 4 | 2021 | 26581 | 0.040 |
Why?
|
Gene Library | 1 | 1997 | 130 | 0.040 |
Why?
|
Chromosome Duplication | 1 | 2016 | 8 | 0.040 |
Why?
|
Receptors, Dopamine D2 | 1 | 1996 | 57 | 0.040 |
Why?
|
Genomic Imprinting | 1 | 2016 | 33 | 0.040 |
Why?
|
Pandemics | 1 | 2022 | 740 | 0.030 |
Why?
|
Neuregulin-1 | 2 | 2006 | 13 | 0.030 |
Why?
|
Neurodevelopmental Disorders | 1 | 2016 | 36 | 0.030 |
Why?
|
Chromosomes, Human, Pair 10 | 2 | 2008 | 47 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2001 | 813 | 0.030 |
Why?
|
Rats | 1 | 2021 | 3990 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 1996 | 927 | 0.030 |
Why?
|
Surveys and Questionnaires | 1 | 2022 | 2501 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2014 | 268 | 0.030 |
Why?
|
Nuclear Family | 3 | 2000 | 92 | 0.030 |
Why?
|
Prospective Studies | 1 | 2022 | 4210 | 0.030 |
Why?
|
Sweden | 1 | 2013 | 40 | 0.030 |
Why?
|
Protein Binding | 1 | 2017 | 1456 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2013 | 62 | 0.030 |
Why?
|
Inheritance Patterns | 1 | 2013 | 48 | 0.030 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2013 | 39 | 0.030 |
Why?
|
Base Composition | 1 | 2013 | 35 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 1998 | 1135 | 0.030 |
Why?
|
HapMap Project | 1 | 2013 | 47 | 0.030 |
Why?
|
Half-Life | 1 | 2013 | 96 | 0.030 |
Why?
|
Genetic Carrier Screening | 1 | 1993 | 60 | 0.030 |
Why?
|
Codon, Nonsense | 1 | 2013 | 41 | 0.030 |
Why?
|
Adolescent Development | 1 | 2012 | 18 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2012 | 111 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2018 | 1578 | 0.030 |
Why?
|
Computer Simulation | 1 | 2016 | 1078 | 0.030 |
Why?
|
Alzheimer Disease | 1 | 2016 | 470 | 0.030 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2013 | 183 | 0.030 |
Why?
|
Cognition | 1 | 2016 | 570 | 0.030 |
Why?
|
Genes, Recessive | 2 | 2002 | 87 | 0.020 |
Why?
|
Twin Studies as Topic | 1 | 2011 | 19 | 0.020 |
Why?
|
Genetic Pleiotropy | 1 | 2011 | 24 | 0.020 |
Why?
|
Age Factors | 1 | 2015 | 1849 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2013 | 912 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2012 | 294 | 0.020 |
Why?
|
Random Allocation | 1 | 2011 | 332 | 0.020 |
Why?
|
Odds Ratio | 1 | 2012 | 678 | 0.020 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2009 | 19 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2010 | 96 | 0.020 |
Why?
|
Twins | 1 | 2010 | 65 | 0.020 |
Why?
|
Lung Diseases | 1 | 2012 | 263 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2013 | 1019 | 0.020 |
Why?
|
Transcription Factors | 1 | 2017 | 1565 | 0.020 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 2009 | 52 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2009 | 155 | 0.020 |
Why?
|
Statistics, Nonparametric | 2 | 2000 | 307 | 0.020 |
Why?
|
Major Histocompatibility Complex | 1 | 2009 | 81 | 0.020 |
Why?
|
Genetics, Population | 1 | 2012 | 394 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2014 | 2426 | 0.020 |
Why?
|
Algorithms | 1 | 2016 | 1830 | 0.020 |
Why?
|
Environment | 1 | 2010 | 219 | 0.020 |
Why?
|
Dysbindin | 1 | 2007 | 2 | 0.020 |
Why?
|
Dystrophin-Associated Proteins | 1 | 2007 | 2 | 0.020 |
Why?
|
Crohn Disease | 1 | 2013 | 730 | 0.020 |
Why?
|
Recurrence | 1 | 2010 | 1139 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2012 | 1801 | 0.020 |
Why?
|
Sex Factors | 1 | 2010 | 1054 | 0.020 |
Why?
|
5' Untranslated Regions | 1 | 2003 | 49 | 0.010 |
Why?
|
Transcription Factor AP-1 | 1 | 2003 | 65 | 0.010 |
Why?
|
CHO Cells | 1 | 2003 | 187 | 0.010 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2004 | 115 | 0.010 |
Why?
|
Oligonucleotides | 1 | 2003 | 92 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2004 | 260 | 0.010 |
Why?
|
Cricetinae | 1 | 2003 | 560 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2004 | 526 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2003 | 280 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 879 | 0.010 |
Why?
|
Africa | 1 | 2002 | 98 | 0.010 |
Why?
|
Australia | 1 | 2002 | 99 | 0.010 |
Why?
|
Child | 1 | 2013 | 6926 | 0.010 |
Why?
|
Canada | 1 | 2002 | 204 | 0.010 |
Why?
|
Family Health | 1 | 2001 | 162 | 0.010 |
Why?
|
Infant | 2 | 1998 | 3045 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2003 | 378 | 0.010 |
Why?
|
Matched-Pair Analysis | 1 | 2000 | 43 | 0.010 |
Why?
|
Genes, Dominant | 1 | 2000 | 117 | 0.010 |
Why?
|
Databases as Topic | 1 | 2000 | 92 | 0.010 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2000 | 109 | 0.010 |
Why?
|
Up-Regulation | 1 | 2003 | 712 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2012 | 2261 | 0.010 |
Why?
|
Sequence Tagged Sites | 1 | 1997 | 11 | 0.010 |
Why?
|
Chromosomes, Artificial, Yeast | 1 | 1997 | 37 | 0.010 |
Why?
|
National Institute of Mental Health (U.S.) | 1 | 1997 | 22 | 0.010 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 1997 | 32 | 0.010 |
Why?
|
Hybrid Cells | 1 | 1997 | 72 | 0.010 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 1997 | 48 | 0.010 |
Why?
|
Deoxyribonuclease EcoRI | 1 | 1997 | 7 | 0.010 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 1997 | 59 | 0.010 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 1997 | 86 | 0.010 |
Why?
|
Receptors, Dopamine D3 | 1 | 1996 | 18 | 0.010 |
Why?
|
Introns | 1 | 1998 | 289 | 0.010 |
Why?
|
Likelihood Functions | 1 | 1997 | 251 | 0.010 |
Why?
|
Alternative Splicing | 1 | 1998 | 201 | 0.010 |
Why?
|
Homozygote | 1 | 1996 | 200 | 0.010 |
Why?
|
Exons | 1 | 1998 | 450 | 0.010 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1996 | 135 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 1998 | 736 | 0.010 |
Why?
|
Heterozygote | 1 | 1996 | 365 | 0.010 |
Why?
|
Models, Statistical | 1 | 1999 | 574 | 0.010 |
Why?
|
Risk Assessment | 1 | 1996 | 2261 | 0.010 |
Why?
|